Both clinical trial and real-world data valuable in maternal care
Clinical trials and real-world data have unique strengths and weaknesses when it comes to advancing maternity care for diseases like FNAIT.
Clinical trials and real-world data have unique strengths and weaknesses when it comes to advancing maternity care for diseases like FNAIT.
Learn more about the symptoms to watch out for that may indicate your child experienced a brain bleed as an infant.
A recent study found that several forms of exercise, including yoga and Pilates, may alleviate symptoms of perinatal anxiety and depression.
Conducting clinical trials involving pregnant individuals, as is the case in FNAIT, requires careful consideration to protect patient safety.
While matched platelets are preferred for individuals with FNAIT, unmatched ones can also be used when necessary.
The HLA/HPA Platelet Program at Canadian Blood Services, which serves patients with FNAIT, has seen an increased need for matched platelets.
Certain anti-HPA-1a antibodies can cause platelet aggregation through the FcγRIIa receptor, a mechanism that may contribute to FNAIT.
Learn more about the role and function of the spleen, which is a major site of platelet destruction, in FNAIT.
Researchers developed a three-dimensional model to study the mechanisms behind intraventricular hemorrhage.
A woman who experienced a miscarriage did not respond to several platelet transfusions due to the presence of anti-platelet antibodies.